Works matching IS 1082801X AND DT 2004 AND VI 39 AND IP 5
Results: 27
Erectile dysfunction: a review and update.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
Selected websites.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 272
- Publication type:
- Article
Erectile dysfunction: A review and update.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 261
- By:
- Publication type:
- Article
Rasagiline.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 255
- By:
- Publication type:
- Article
Selected literature.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 272
- Publication type:
- Article
Agents for Parkinson's disease.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 272
- Publication type:
- Article
Rasagiline: an oral irreversible MAO-B inhibitor for the treatment of Parkinson's disease.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
Changes to incentive-based formularies should be made gradually.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 252
- By:
- Publication type:
- Article
Safety labeling updates & new warnings.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 250
- Publication type:
- Article
Valproate improves 1-year IGE remission rate by more than 50%.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 248
- Publication type:
- Article
ICS use elevates fracture risk in COPD patients.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 250
- Publication type:
- Article
Zyprexa IntraMuscular.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 240
- Publication type:
- Article
Long-term safety of alendronate established in 10-year study.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 249
- Publication type:
- Article
COX inhibitors counter the effects of ACE inhibitors, elevate BP.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 249
- Publication type:
- Article
Acarbose prevents MI in patients with type 2 diabetes.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 248
- Publication type:
- Article
Health plans focus on new strategies to educate consumers about formularies.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 246
- Publication type:
- Article
Combination atopic dermatitis therapy reduces adverse effects.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 245
- Publication type:
- Article
New class may help smokers quit, curb post-cessation weight gain.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 245
- Publication type:
- Article
Enoxaparin clinically equivalent to UFH in the treatment of high-risk ACS.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 242
- Publication type:
- Article
Perfusion scanning following AMI can identify low-risk group.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 242
- Publication type:
- Article
Ezetimibe added to statin results in greater achievement of LDL goals.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 242
- Publication type:
- Article
FDA actions in brief.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 240
- Publication type:
- Article
First-time generic approvals.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 239
- Publication type:
- Article
Cardizem LA.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 239
- Publication type:
- Article
Vioxx.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 235
- Publication type:
- Article
Ketek.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 235
- Publication type:
- Article
Pipeline preview.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 235
- Publication type:
- Article